Trial Profile
A study evaluating safety and efficacy of rivaroxaban discharge initiative in the treatment of acute venous thromboembolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium; Warfarin
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 08 Sep 2017 New trial record
- 02 Aug 2017 This initiative was started in late 2014 as per the results published in the American Journal of Emergency Medicine
- 02 Aug 2017 Results published in the American Journal of Emergency Medicine